Publication | Closed Access

A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin

ThrombosisCardiovascular DiseaseMyocardial InfarctionAcute Myocardial InfarctionVersus High-dose RosuvastatinMedicineCardiologyCoronary Artery DiseaseCoronary Heart DiseaseChinese Patients